1D8.SI - Singapore O&G Ltd.

SES - SES Delayed Price. Currency in SGD

Singapore O&G Ltd.

No. 02-02, Mountbatten Square
229 Mountbatten Road
Singapore 398007
65 6440 4123

IndustryMedical Care Facilities
Full-time employees80

Key executives

NameTitlePayExercisedYear born
Dr. Suan Tiong BehExec. Chairman521.82kN/A1963
Dr. Tung Lan HengExec. Director1.21MN/A1957
Dr. Keen Whye LeeExec. Director406.25kN/A1954
Dr. Eng Kien LauChief Exec. OfficerN/AN/AN/A
Ms. Wai Yin Doreen ChewChief Financial OfficerN/AN/AN/A
Amounts are as of 31 December 2018, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SGD.


Singapore O&G Ltd., an investment holding company, provides specialist medical and surgical services for women and children in Singapore. The company operates through Obstetrics and Gynaecology, Cancer-Related, Dermatology, and Paediatrics segments. It offers obstetric services, including general obstetrics, labor, and delivery; medical problems in pregnancy; and obstetrical complications and its management. The company also provides general gynaecology and surgery, gynaecologic surgery, female pelvic medicine, urogynaecology, and reconstructive surgery services, as well as cancer-related services for gynae-oncology, breast, and general surgery. In addition, it offers dermatology services comprising aesthetic dermatological procedures, dermatologic and laser surgeries, and general skin care services; and paediatrics services, such as newborn and well-baby checks, childhood immunization routine and vaccinations, acute paediatrics infections, and common childhood conditions, as well as child nutrients, growth, and developmental assessment. The company operates 14 clinics. Singapore O&G Ltd. was incorporated in 2011 and is based in Singapore.

Corporate governance

Singapore O&G Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.